Unique Issues Facing Brand-Compounder Patent Litigation
By Michael Abernathy, Christopher Betti and Michael Sikora · March 5, 2026, 5:55 PM EST
Recent developments involving compounded GLP-1 tablet products have fostered questions about compounding pharmacies as new and substantial sources of prescription drugs, and whether intellectual property disputes may increase....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login